HomeNews

Photocure ASA: Share Option Program

Published: 4 April 2013
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

News and events

PRESS-RELEASE
Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference
Oslo, Norway
17 September 2024
NEWS POST
New publication: blue light cystoscopy shows potential to facilitate the diagnosis of CIS in the upper urinary tract
Oslo, Norway
30 August 2024
OSE Notice
Photocure ASA: Results for the second quarter of 2024
Oslo, Norway
7 August 2024
OSE Notice
Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results
Oslo, Norway
31 July 2024
OSE Notice
Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization
Oslo, Norway
15 July 2024
NEWS POST
New Photocure White Paper: Beyond the buzzwords – How AI and advancing diagnostic technologies will transform early bladder cancer care
Oslo, Norway
19 June 2024
PRESS-RELEASE
Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.
Oslo, Norway
4 June 2024
OSE Notice
Photocure ASA – Annual general meeting held
Oslo, Norway
23 May 2024
OSE Notice
Photocure ASA: Results for the first quarter of 2024
Oslo, Norway
15 May 2024
PRESS-RELEASE
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
Oslo, Norway
12 May 2024
OSE Notice
Photocure ASA: Invitation to presentation of first quarter 2024 financial results
Oslo, Norway
8 May 2024
PRESS-RELEASE
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
Oslo, Norway
7 May 2024
OSE Notice
Photocure ASA – Notice of the Annual General Meeting 23 May 2024
Oslo, Norway
30 April 2024
OSE Notice
Photocure ASA: Annual Report 2023
Oslo, Norway
30 April 2024
PRESS-RELEASE
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy
Oslo, Norway
30 April 2024
OSE Notice
Photocure ASA – Share option grant
Oslo, Norway
25 April 2024
GLOBAL HEADQUARTERS

Photocure ASA
Hoffsveien 4
0275 Oslo
Norway

E-mail: info@photocure.no
NORTH AMERICA

Photocure INC
202 Carnegie Center
Suite 101, Princeton,
NJ 08540, USA

E-mail: info@photocure.com
EUROPE

Photocure GmbH 
Breite Str. 27 
40213 Düsseldorf 
Germany

E-mail: kontakt@photocure.com
Follow us
Privacy PolicyTerms of use
© Photocure 2024